A new combination of pre-existing drugs may have unlocked a new treatment for bipolar depression, a Columbia University study released Wednesday found. The study suggests a way to prolong the effects ...
Led by University of Cincinnati and Cincinnati Children’s researchers, new trial results published in The Lancet Psychiatry found the drug metformin can help manage weight gain in youth taking ...
The FDA is reviewing risperidone (Uzedy) extended-release injectable suspension for maintenance treatment of adults with bipolar I disorder, said makers Teva Pharmaceuticals and Medincell. The drug ...
Electroconvulsive therapy (ECT) appears to be far more effective than algorithm-based drug therapy for treatment-resistant bipolar depression in what is believed to be the first randomized, controlled ...
Most estimates suggest that about 2% of adults have bipolar disorder, but depending on the epidemiological data used, some studies put the figure as high as 10%. There has also been a surge of ...
Shares of BioXcel Therapeutics rose after the company said it received positive comments from the FDA about its treatment of agitation associated with bipolar disorders or schizophrenia. The stock was ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback